Recruiting

Observational Study

Sponsor:

RenovoRx

Code:

NCT06805461

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RenovoCath®

Study Details

Brief summary:

This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.

Conditions

Solid Tumors

Study ID

NCT06805461

Start date

Aug 1, 2025

Status verified date

Oct, 2025

Completion date

Sep 3, 2029

Anticipated

Primary completion date

Sep 3, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Eligibility Criteria:

1. Male and female patients who have been diagnosed with solid tumor cancers and are at least 18 years of age at the time of the first IA procedure
2. Patients willing to provide informed consent and HIPAA release for use of their relevant medical records

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients receiving Intra-Arterial treatment with RenovoCath

Patients receiving Intra-Arterial treatment with RenovoCath

Interventions

RenovoCath®

Intra-arterial catheter delivery of chemotherapy agents for the collection of real-world data.

Primary outcome measure

  • Safety of RenovoCath® as assessed by the number of participants experiencing adverse events related to the chemotherapy agents administered using RenovoCath. [ Time Frame: From the time of the first treatment, until 30 days after the last treatment ]
  • Performance of RenovoCath® as assessed by the number of participants experiencing adverse events related to the inter-arterial drug delivery procedure. [ Time Frame: From the time of the first treatment, until 30 days after the last treatment ]

Central Contacts and Locations

Central contacts

Leesa M Gentry

650-284-4433lgentry@renovorx.com

Nicolette G Keller

650-284-4433nkeller@renovorx.com

Locations

Baptist Health South Florida

Recruiting

Coral Gables, Florida, United States, 33143

University of Pennsylvania Medical Center

Recruiting

Pittsburgh, Pennsylvania, United States, 15213

The University of Vermont Medical Center

Recruiting

Burlington, Vermont, United States, 05401

More Information

Sponsor

RenovoRx

Last update posted

Mar 30, 2026

Last verified

Oct, 2025

Keywords

  • Intra-Arterial Catheter

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by RenovoRx on 2026-03-30.